Leonard M. Greenstein
Net Worth
Last updated:
What is Leonard M. Greenstein net worth?
The estimated net worth of Mr. Leonard M. Greenstein is at least $3,388,217 as of 20 Apr 2023. He owns shares worth $1,438,355 as insider, has earned $699,642 from insider trading and has received compensation worth at least $1,250,220 in Tarsus Pharmaceuticals, Inc..
What is the salary of Leonard M. Greenstein?
Mr. Leonard M. Greenstein salary is $416,740 per year as Chief Financial Officer in Tarsus Pharmaceuticals, Inc..
How old is Leonard M. Greenstein?
Mr. Leonard M. Greenstein is 49 years old, born in 1976.
What stocks does Leonard M. Greenstein currently own?
As insider, Mr. Leonard M. Greenstein owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer | 26,785 | $53.7 | $1,438,355 |
What does Tarsus Pharmaceuticals, Inc. do?
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Leonard M. Greenstein insider trading
Tarsus Pharmaceuticals, Inc.
Mr. Leonard M. Greenstein has made 14 insider trades between 2022-2023, according to the Form 4 filled with the SEC. Most recently he sold 5,000 units of TARS stock worth $70,100 on 20 Apr 2023.
The largest trade he's ever made was exercising 5,000 units of TARS stock on 18 Aug 2022. As of 20 Apr 2023 he still owns at least 26,785 units of TARS stock.
Tarsus Pharmaceuticals key executives
Tarsus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Seshadri Neervannan Ph.D. (57) Chief Operating Officer
- Mr. Leonard M. Greenstein (49) Chief Financial Officer